Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zafardjan Dalimov

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Surgical Oncology|December 1, 2023
Preoperative optimization of the radical cystectomy patient: Current state and future directionsJeffrey L Ellis, Zafardjan Dalimov, Lauren Chew, et al.
International Journal of Impotence Research|October 5, 2022
Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantationJohnathan A Drevik, Zafardjan Dalimov, Jacob Lucas, et al.
Journal of Endourology|September 22, 2022
Percutaneous Nephrolithotomy Access: A Meta-Analysis Comparing Access by Urologist <i>vs</i> RadiologistJoshua Ghoulian, Alex Nourian, Zafardjan Dalimov, et al.
Urology|July 18, 2021
Neuraxial vs General Anesthesia: 30-Day Mortality Outcomes Following Transurethral Resection of ProstateOussama M Darwish, Ellen Lutnick, Zafardjan Dalimov, et al.
Oncotarget|May 12, 2015
Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migrationAo Zhang, Masahiro Hitomi, Noah Bar-Shain, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 12, 2020
Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate CancerDeborah L Burkhart, Katherine L Morel, Kristine M Wadosky, et al.
Oncotarget|January 22, 2015
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancerJason S Kirk, Kevin Schaarschuch, Zafardjan Dalimov, et al.
Oncotarget|May 4, 2023
Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migrationAo Zhang, Masahiro Hitomi, Noah Bar-Shain, et al.
Urologic Oncology|September 26, 2022
Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborativeJohnathan Drevik, Zafardjan Dalimov, Robert Uzzo, et al.
Urology|October 28, 2021
Intracorporeal Versus Extracorporeal Neobladder After Robot-assisted Radical Cystectomy: Results From the International Robotic Cystectomy ConsortiumZafardjan Dalimov, Umar Iqbal, Zhe Jing, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Surgical Oncology|December 1, 2023
Preoperative optimization of the radical cystectomy patient: Current state and future directionsJeffrey L Ellis, Zafardjan Dalimov, Lauren Chew, et al.
International Journal of Impotence Research|October 5, 2022
Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantationJohnathan A Drevik, Zafardjan Dalimov, Jacob Lucas, et al.
Journal of Endourology|September 22, 2022
Percutaneous Nephrolithotomy Access: A Meta-Analysis Comparing Access by Urologist <i>vs</i> RadiologistJoshua Ghoulian, Alex Nourian, Zafardjan Dalimov, et al.
Urology|July 18, 2021
Neuraxial vs General Anesthesia: 30-Day Mortality Outcomes Following Transurethral Resection of ProstateOussama M Darwish, Ellen Lutnick, Zafardjan Dalimov, et al.
Oncotarget|May 12, 2015
Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migrationAo Zhang, Masahiro Hitomi, Noah Bar-Shain, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 12, 2020
Evidence that EZH2 Deregulation is an Actionable Therapeutic Target for Prevention of Prostate CancerDeborah L Burkhart, Katherine L Morel, Kristine M Wadosky, et al.
Oncotarget|January 22, 2015
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancerJason S Kirk, Kevin Schaarschuch, Zafardjan Dalimov, et al.
Oncotarget|May 4, 2023
Correction: Connexin 43 expression is associated with increased malignancy in prostate cancer cell lines and functions to promote migrationAo Zhang, Masahiro Hitomi, Noah Bar-Shain, et al.
Urologic Oncology|September 26, 2022
Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborativeJohnathan Drevik, Zafardjan Dalimov, Robert Uzzo, et al.
Urology|October 28, 2021
Intracorporeal Versus Extracorporeal Neobladder After Robot-assisted Radical Cystectomy: Results From the International Robotic Cystectomy ConsortiumZafardjan Dalimov, Umar Iqbal, Zhe Jing, et al.
Pageof 2